Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by bealerton Feb 27, 2024 3:00pm
88 Views
Post# 35902108

RE:RE:RE:RE:PRC Partners (June 2022)

RE:RE:RE:RE:PRC Partners (June 2022)Forhand, after being told numerous falsehoods over the years, the fact that the AbbVie deal hasn't come to fruition yet after the big hype, indicates that we as investors have been SCAMMED again with the HUGE hollow carrot.

It shouldn't have taken that long to get to market and the big reveal here is that there has been NO updates to any indications of marketability to this date.  That smells of SCAM to anyone in the investment community that wants to believe the 'BOSS'.

Fact is, that after over 16 years, we still don't have a product on the shelves, period!  What else can I say as an investor???

Sirona motto is:   Shhhhhhh, we can't release and details because of confidentiality in the AGREEMENT.

BeAlert

<< Previous
Bullboard Posts
Next >>